Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian carcinoma.

D N Carney

    Irish Journal of Medical Science
    |January 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Advances in ovarian carcinoma treatment have improved survival, but cures remain rare for advanced stages. Future efforts focus on earlier detection and novel therapies like biological response modifiers to enhance patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Osteosarcoma and second malignant neoplasms: a case series.

    Irish journal of medical science·2019
    Same author

    Is chemotherapy always required for cancer in pregnancy? An observational study.

    Irish journal of medical science·2017
    Same author

    Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy.

    Irish medical journal·2016
    Same author

    Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review.

    Clinical sarcoma research·2015
    Same author

    Primary bone lymphoma: single institution case series.

    Irish journal of medical science·2008
    Same author

    Predictive testing for BRCA1 and 2 mutations: a male contribution.

    Annals of oncology : official journal of the European Society for Medical Oncology·2003
    Same journal

    Real-world antipsychotic prescribing patterns in psychotic disorders: polypharmacy, clozapine, and long-acting injectable use in a tertiary outpatient cohort.

    Irish journal of medical science·2026
    Same journal

    Effects of adding Kinesiotaping to conventional physiotherapy on pain, function, and Kinesiophobia in knee osteoarthritis: A randomized controlled trial.

    Irish journal of medical science·2026
    Same journal

    Neonatal predictors of neurodevelopment: the interplay between APGAR score and neonatal microbiome.

    Irish journal of medical science·2026
    Same journal

    Polypharmacy in glaucoma management: a narrative review.

    Irish journal of medical science·2026
    Same journal

    Weight-adjusted adenosine and first-dose conversion success in supraventricular tachycardia: a prospective cohort study.

    Irish journal of medical science·2026
    Same journal

    Adenomyosis is not an independent prognostic factor in endometrioid-type endometrial cancer.

    Irish journal of medical science·2026
    See all related articles

    Area of Science:

    • Oncology
    • Gynecologic Oncology

    Background:

    • Ovarian carcinoma treatment has seen significant progress over the last decade.
    • Cytotoxic chemotherapy and radiotherapy have improved survival rates, even in advanced cases.

    Purpose of the Study:

    • To review recent advances in understanding ovarian carcinoma biology and treatment.
    • To highlight the need for earlier detection and novel therapeutic strategies.

    Main Methods:

    • Review of current literature on ovarian carcinoma treatment modalities.
    • Analysis of survival data and treatment impacts.

    Main Results:

    • Chemotherapy and radiotherapy have positively impacted overall survival for ovarian carcinoma patients.
    • Few patients with advanced ovarian carcinoma achieve a cure with current standard treatments.

    Related Experiment Videos

    Conclusions:

    • Maintaining survival improvements necessitates earlier ovarian carcinoma detection.
    • Exploring alternative therapies, including monoclonal antibodies, biological response modifiers (e.g., interferons), and drugs overcoming resistance, holds promise for improved patient survival.